Navigation Links
BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
Date:10/16/2007

xus CGH from leading research institutions including UCSF, Johns Hopkins, UCLA, NIH, The Norwegian Radium Hospital, UCD, Duke, City of Hope, Harvard, and Dundee University," said Dr. Soheil Shams, CEO, BioDiscovery, Inc. "Nexus CGH version 2 enables scientists to convert mountains of copy number data into actionable knowledge in a matter of minutes."

About BioDiscovery

BioDiscovery is a leader in the development of microarray advanced bioinformatics software and services that enable its customers to revolutionize drug discovery and diagnostics by efficiently managing, integrating, and analyzing data generated using high-throughput microarray technology. Contact us: 310-414-8100 or http://www.biodiscovery.com.


'/>"/>
SOURCE BioDiscovery, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine news :

1. Sweet corn releases antioxidants on cooking
2. An International Growth Standard For Childs Releases By WHO
3. The National Governors Association Releases Guidelines For Outbreak Of Bird Flu
4. Eli Lilly Releases Digital Insulin Pen
5. Nexus Between Psychiatrists and Drug Firms Dangerous, Say Critics
6. Sun Pharma to launch chiral version of omeprazole soon
7. Slimmer’s Delight: Potato Version 2, on a platte
8. Friends of Earth Protest water Diversion Project ,Garrison-II.
9. Latest Version of Echocardiography Provides Improved Pictures of the Heart
10. First Generic Version of Lexapro permitted by US
11. Sun Pharma Allots Shares Upon Fccbs Conversion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2008)... Dr. Stephen Cohen Hired As New CEO, ATLANTA,...r Group,(GMCG) announced today that MELCO Investme...ment fund, has signed on as a key partner with a,s...the investment, GMCG has,also appointed Dr. Stephe...,surgeons, as its new CEO., (Photo: http://www.n...
(Date:7/23/2008)...d and Medicare Rules Highlighted; a Focus on Preve...tions, LANSING, Mich., July 23 /PRNewswire/ -- Th...&PSI), a national leader in clinical risk manageme... care institutions and,providers, today announced ... conference., The conference will take place Sept...
(Date:7/23/2008)... Michigan Takes Top Honors as the #1 Healthiest Ci...PRNewswire-USNewswire/ -- AARP The Magazine, the,d...largest-circulation,magazine with more than 34 mil...st cities to live and retire in with Ann Arbor, MI...go, ND taking the top five rankings.,Featured in t...
(Date:7/23/2008)...a., July 23 /PRNewswire-USNewswire/ -- The HealthC...m ) today announced that Dr. Fran Cogen,MD, direc...am at Children,s,National Medical Center, will pro...om, a site offering connections to a community of ...priate consultation by a dietician, social,worker,...
Breaking Medicine News(10 mins):Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5Health News:Children's National Medical Center Program Director to Provide Expertise to DiabeTeens.com, The HealthCentral Network's Teen Diabetes Site 2
... rampant felling of trees for construction purpose...sities in Delhi have raised their voice to save t...e students of Delhi University (DU) have forwarded...eepak Pental objecting to the plan to cut 1,000 tr...
...-enhanced ultrasound (CE-US) after a liver transpl... as biliary complications , according to a recent ... recipients who underwent a CE-US exam after devel...clear liver function tests. "Acute liver failure i...
...vely easy and reliable test is on the cards for pr...ening risks to expectant mothers and their babies...mplication which could kill hundreds of fetuses a ...a test. One in ten pregnancies is fraught with suc...
...niversity researchers seem to know what makes cert...nts. Colleagues from Edinburgh University and the ...losed in on the possible risk factors in premature... expose them to risks of cot death. Professors An...
Other Medicine News:Health News:Students Join Hands to Save Green Cover in Delhi 2Health News:Spit Test Kit on the Cards to Ascertain Pre-eclampsia Risk 2
(Date:7/21/2008)...iev, M.D., president of SPRI,Clinical Trials, will...Wall,Street Unplugged: The Trout Group Investor Se...nference will be held on Wednesday, July 30, at Mi.... The event is targeted to CEOs,and CFOs at privat...gain,better insight into Wall Street and maximize ...
(Date:7/21/2008)...S (Simvastatin and Ezetimibe in,Aortic Stenosis) s...lesterol lowering with the combination of simvasta...atients with aortic stenosis., Aortic stenosis (w... in,the heart) is a relatively common disease amon...ted, it can progress to death from heart failure o...
(Date:7/21/2008)...S Study" issued on 21 Jul 2008,07:00 GMT, by Prof ... Head,of Steering Committee over PR Newswire, we a... that the following information has been added to ...ess and URL for webcast:, Satellite: European Sa...l 2 DL: 11152.700 V symbol rate 5.632 FEC 3/4, ...
(Date:7/21/2008)...s identify risk in patients, including non-diab...y, BIRMINGHAM, Ala., July 21 /- Usin...chers have identified a link between,adiponectin a...d help,physicians trying to pinpoint the most effe...treatments in at-risk patients., The association ...
Breaking Medicine Technology:Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 2Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 3Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study 4/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 2/C O R R E C T I O N -- Prof Terje Pedersen, SEAS Study Principal Investigator & Head of Steering Committee/ 3VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 2VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels and Atherosclerosis 3Doctors Slow to Embrace Electronic Medical Records 22245 1Doctors Slow to Embrace Electronic Medical Records 22245 2Doctors Slow to Embrace Electronic Medical Records 22245 3Psych Central Selected by TIME Magazine as Top 50 Web Site in 2008 for Its Top Mental Health Content and Social Media Platform 22241 1Psych Central Selected by TIME Magazine as Top 50 Web Site in 2008 for Its Top Mental Health Content and Social Media Platform 22241 2Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 1Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 2Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 3Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 4Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants 6091 5AAHSA Statement on Nursing Home Rating System 22237 1AAHSA Statement on Nursing Home Rating System 22237 2
... - Abraxis BioScience,Inc. (NASDAQ:ABBI), an inte...d first-time data from a pre-clinical study,evalua...mycin,(ABI-009), an albumin-bound mTOR kinase inhi... Research (AACR) Annual Meeting held,April 14-18, ...,study demonstrated that nab-rapamycin was well-to...
...r 19, 2007 - Amgen,(NASDAQ: AMGN) today announced ...le-blind, placebo-controlled, multicenter Phase 3,...iously untreated,patients with extensive-stage sma...aining chemotherapy. The study demonstrated,no sta... (overall,survival Aranesp compared to placebo Haz...
Other Medicine Technology:Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 2Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 3Abraxis BioScience Presents Results from Pre-Clinical Study That,Demonstrates nab-Rapamycin's Robust Antitumor Properties and,Ability to Target Intracellular Sites Such as the mTOR Pathway 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 2Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 3Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 4Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 5Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 6Aranesp ``145 Study'' Shows No Difference in Survival in Patients,with Small-Cell Lung Cancer 7
This stain is a classical hematology stain that requires a longer staining time but produces a very dense coloration. It is used in the staining of peripheral blood smears and bone marrows. The resul
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast.
Albumin reagent is used for the quantitative determination of albumin concentration in human serum.
AST (SGOT) reagent is used for the quantitative determination of aspartate aminotransferase (AST) in human serum.
Medicine Products: